A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2004
10/13/2004	EP1465636A2 Compositions and methods for enhancing corticosteriod delivery
10/13/2004	EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
10/13/2004	EP1465625A2 Solubilized topoisomerase poisons
10/13/2004	EP1465619A1 Suppression of cartilage degradation via the estrogen receptor
10/13/2004	EP1465577A2 Methods for improving the aesthetic appearance of skin
10/13/2004	EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/13/2004	EP1322309A4 High affinity small molecule c5a receptor modulators
10/13/2004	EP1280820B1 Anti-inflammatory compounds and uses thereof
10/13/2004	EP1268472B1 3-aminopyrazole inhibitors of cyclin dependent kinases
10/13/2004	EP1207840B1 Pharmaceutical compositions and methods for reducing the appearance of cellulite
10/13/2004	EP1206436B1 Retinoids for the treatment of emphysema
10/13/2004	EP1202965B1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application
10/13/2004	EP1169038A4 Cyclic protein tyrosine kinase inhibitors
10/13/2004	EP1165533B1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/13/2004	EP1150954B1 Anti-imflammatory indole derivatives
10/13/2004	EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands
10/13/2004	EP1005458B1 Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation
10/13/2004	EP0986389B1 Novel process
10/13/2004	EP0840616B1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases
10/13/2004	CN1537115A C2,5'-disubstituted and N6, C2, 5' trisubstituted adenosine derivatives and their different uses
10/13/2004	CN1537112A Pyrimidine compound
10/13/2004	CN1537111A Urea substituted imidazoquinolines
10/13/2004	CN1537105A Quinazolines as MMP-13 inhibitors
10/13/2004	CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
10/13/2004	CN1537094A Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities
10/13/2004	CN1537093A Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
10/13/2004	CN1537019A Medical combination of aldosterone receptor antagonist and HMG CoA reductase inhibitor
10/13/2004	CN1537015A Stable liquid formulations of antibodies
10/13/2004	CN1537014A HMGB1 protein inhibitors and/or antagonisis for treatment vascular diseases
10/13/2004	CN1537009A Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method
10/13/2004	CN1537003A Pharmaceutical composition comprising tricyclic compound for prevention or treatment of skin diseases
10/13/2004	CN1537002A Novel theterocyclic analogs of diphenylethylene compounds
10/13/2004	CN1535983A Blood vessel generating inhibitor
10/13/2004	CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative
10/13/2004	CN1535711A Medicine composition for curing burn, scald and mucocutaneous ulcer
10/13/2004	CN1535709A Capsicum ethylsine tablet preparation and its preparation method
10/13/2004	CN1535687A Antipruritic
10/13/2004	CN1535685A Adhesive plaster for curing neurodermatitis
10/13/2004	CN1535670A Application of compound containing easily-oxidable hydrophilic active component and stabilized by maleic anhydride copolymer in face beautifying and/or dermological field
10/13/2004	CN1535622A Processing process for making beverage and food by using duck wheat as raw material
10/13/2004	CN1170849C Connective tissue growth factor fragments and methods and uses thereof
10/13/2004	CN1170575C Exterio-applied medical wine for treating trauma
10/13/2004	CN1170573C Hari-growing medicine and its prepn method
10/13/2004	CN1170570C Detoxicating ointment for treating burn and scald and its preparing process
10/13/2004	CN1170565C Cancer treating astringent medicine decoction
10/13/2004	CN1170558C Medicine for treating thrombocytopenia and its application in treating radiation disease
10/13/2004	CN1170555C Chinese patent medicine for treating ulcer diseases
10/13/2004	CN1170546C Compound alum powder and its prepn
10/13/2004	CN1170545C Medical composition for treating tragomaschalia, beriberi and stomatosis
10/12/2004	US6803384 Diaminopropionic acid derivatives
10/12/2004	US6803362 Heterocyclic compounds
10/12/2004	US6803359 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
10/12/2004	US6803211 Cancer therapy
10/07/2004	WO2004085486A1 Composition for external use on skin
10/07/2004	WO2004085452A1 Compound having affinity with calcified tissue
10/07/2004	WO2004085429A1 Composition for promoting production of type i collagen and/or elastin
10/07/2004	WO2004085423A1 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state
10/07/2004	WO2004085399A1 Oxamide derivatives useful as raf-kinase inhibitors
10/07/2004	WO2004085373A1 Novel shogaol compound and tyrosinase activity inhibitor comprising the compound
10/07/2004	WO2004084929A1 USE OF proNGF, IN PARTICULAR FOR HEALING WOUNDS OF THE CORNEA AND THE SKIN
10/07/2004	WO2004084918A1 Antipruritic composition for external use on skin
10/07/2004	WO2004084905A2 Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions
10/07/2004	WO2004084902A1 Use of a trioxopyrimidine for the treatment of chronic wounds
10/07/2004	WO2004084900A1 Topical formulation and use of buspirone
10/07/2004	WO2004084891A1 Methods for treating inflammatory conditions or inhibiting jnk
10/07/2004	WO2004084883A1 Complexes of isotretinoin with natural beta or gamma-cyclodextrin
10/07/2004	WO2004084848A1 Hair growth stimulant and hair growth stimulating composition
10/07/2004	WO2004084822A2 Methods for inducing immune tolerance
10/07/2004	WO2004012659A3 Nitrosated proton pump inhibitors, compositions and methods of use
10/07/2004	WO2003099195A3 Immunomodulatory compounds and methods of use thereof
10/07/2004	WO2003057725A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
10/07/2004	WO2003053973A8 Pyrazolyl-substituted triazoloquinoxalines
10/07/2004	WO2003049679A3 Mitotic kinesin inhibitors
10/07/2004	WO2002100250A8 Wit 3.0, a novel gene to control soft tissue wound healing
10/07/2004	WO2002088317A3 Fusion molecules and methods for treatment of immune diseases
10/07/2004	US20040198980 Selective rxr ligands
10/07/2004	US20040198978 for treating autoimmune diseases selected from psoriasis, multiple sclerosis and rheumatoid arthritis; N-(3-oxoundecanoyl)-L-homoserine lactone (OuDHL) and 2-n-heptyl-3-hydroxy-4(1H)-quinolone for example
10/07/2004	US20040198961 Fce fusion proteins for treatment of allergy and asthma
10/07/2004	US20040198843 mixture of hydrophobic and polarity moiety; high pressure homogenization of crude oil and water
10/07/2004	US20040198838 Administering by mouth; side effect reduction; multilayer coating on tablet; fungicides
10/07/2004	US20040198832 Compositions and methods for treating amyloidosis
10/07/2004	US20040198830 Carbamic acid compounds comprising an ether linkage as hdac inhibitors
10/07/2004	US20040198782 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration
10/07/2004	US20040198781 Carbonic anhydrase inhibitor
10/07/2004	US20040198776 Methods for increasing leptin levels using nicotinic acid compounds
10/07/2004	US20040198766 Chemical compounds
10/07/2004	US20040198757 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
10/07/2004	US20040198752 Administering retinoids with epidermal growth factor receptor inhibitors
10/07/2004	US20040198749 Methods of using sodium channel blockers
10/07/2004	US20040198748 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders
10/07/2004	US20040198747 Sodium channel blockers
10/07/2004	US20040198746 Sodium channel blockers
10/07/2004	US20040198745 Sodium channel blockers
10/07/2004	US20040198744 Methods of using phenolic guanidine sodium channel blockers
10/07/2004	US20040198743 Administering synergistic mixture
10/07/2004	US20040198737 Azaindoles
10/07/2004	US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
10/07/2004	US20040198725 A bi-heterocyclic compound e.g 3-methoxyphenyl)-{6-Morpholin-4-yl-2-[2-(pyridin-2-yloxy)-ethoxy]-9H-purin-8-yl}-amine or other derivatives useful for treating an interleukin-12 overproduction-related disorder such as rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis or diabetes
10/07/2004	US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
10/07/2004	US20040198718 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them

1 ... 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 ... 1065